Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis

References 

1. Harrison TR, Madkur MM, Kasper DL. In: 15th ed.. Harrison's Principles of Internal Medicine. Vol. 1:New York: McGraw–Hill; 2001;p. 986–991
2. Mandell GL, Benett JE, Dolin R. In: 6th ed.. Principles and Practice of Infectious Disease. Vol. 13:London: Churchill Livingstone; 2005;p. 2669–2674
3. Goldman L, Claude Bennett J. In: 21st ed.. Cecil Textbook of Medicine. Vol. 3:Philadelphia: Saunders Co; 2000;p. 1717–1719
4. Panahi M. Common disease epidemiology in Iran (Brucellosis chapter). Endocrine Research Center of the Medical University of Shahid Beheshti. University Publication; 1993;p. 148–263
5. Acocella G, Bertrand A, Beytout J, Durrande JB, Garcia Rodriguez JA, et al. Comparison of three different regimes in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother. 1989;23:433–439
   • MEDLINE
6. Solera J. Doxicycline–rifampin versus doxicycline–streptomycin in treatment of human brucellosis. Antimicrob Agents Chemother. 1995;39:2061–2067
   • MEDLINE
7. Zowghi E, Ebadi A. Typing of Brucella strains isolated in Iran. Arch Inst Razi. 1997;34:154–155
8. Haddadi A, Mohraz M, Marefat M. Study of brucellosis treatment regimens in brucellosis patients in Imam Khomeini Hospital of Tehran. Iranian Journal of infectious diseases and tropical medicine. 2003;20:29–32
9. Hashemi SH, Farshadi M. Comparison between doxycycline–streptomycin and doxycycline–rifampin drug regimens in treatment of brucellosis. Program and abstracts of the 5th Iranian Congress of Infectious Diseases and Tropical Medicine. 1996; Dec 2–5; 45. Tehran, Iran.
10. Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH. Progressive rise of Mycobacterium tuberculosis resistance to rifampin and streptomycin in Riyadh. Saudi Arabia. Respirology. 2001;6:317–322
11. Solera J, Espinosa A, Martinez-Alfaro A, Sanchez L, Geijo P, Navarro E, et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother. 1997;41:80–84
    • MEDLINE
12. Agalar C, Usubutum S. Ciprofloxacin and rifampin versus doxycyline and rifampin in the treatment of brucellosis. Eur J Clin Microb Infect Dis. 1999;18:535–538
13. Solera J, Espinosa A, Geijo P, Martinez-Alfaro E, Saez L, Sepulveda MA, et al. Treatment of human brucellosis with netilimicin and doxycycline. Clin Infect Dis. 1996;22:441–445
    • MEDLINE
    • CrossRef
14. Saltoglu N, Tasova Y, Inal AS, Seki T, Aksu HS. Efficacy of rifamipicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saudi Med J. 2002;23:921–924
15. Madkour MM. Madkour's brucellosis. Chapter 24. Berlin, Heidelberg, New York: Springer-Verlag; 2001;p. 257
16. Roushan MR, Gangi SM, Ahmadi SA. Comparison of efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly. 2004;134:564–568
    • MEDLINE